How much does a bottle of pomalidomide cost?

Pomalidomide (Pomalidomide) is an immunomodulator that plays a significant role in relapsed or refractory multiple myeloma (RRMM) by enhancing the activity of T cells and natural killer (NK) cells and inhibiting tumor cell proliferation through CRBN-mediated degradation of key transcription factors. It can not only induce leukemia or myeloma cell apoptosis, but also improve the bone marrow microenvironment and enhance the body's immune clearance ability, allowing patients to obtain more durable disease control during the maintenance treatment phase.

Compared with traditional chemotherapy, pomalidomide has relatively mild toxicity in terms of bone marrow suppression, gastrointestinal reactions, and hair loss, and it is easy to maintain for a long time through oral administration. Its clinical value also lies in its ability to be used in combination with low-dose dexamethasone to improve response rate and progression-free survival, providing a reliable option for multi-line treatment.

In terms of price, pomalidomide has been launched in China and has been included in medical insurance, but the price is still relatively high. The actual amount paid after specific reimbursement needs to be confirmed according to local hospital policies and medical insurance standards. In the overseas market, some countries and regions provide relatively low-cost generic drugs. For example, pomalidomide produced in Laos has the same pharmaceutical ingredients as the original drug. The price per bottle is about more than 300 yuan, which may fluctuate slightly due to exchange rates and import policies. These generic drugs provide patients with more accessible treatment options while showing no significant difference in clinical efficacy from the brand-name drugs.

The advantage of pomalidomide is not only its targeted immunomodulatory mechanism, but also its long-term sustainable oral administration mode, which is suitable for continuous treatment of patients with relapsed or refractory myeloma. The drug can stably exert an immune-enhancing effect in the body, and combined with low-dose dexamethasone or other regimens can achieve a higher remission rate and reduce the risk of relapse. At the same time, patients need to regularly monitor their blood count, liver and kidney function, and thrombosis risk during medication to ensure maximum efficacy and safety and controllability.

Reference materials:https://en.wikipedia.org/wiki/Pomalidomide